Is Methyldopa Safe in Pregnancy? What the Guidance Says

If you take methyldopa for high blood pressure and you are pregnant or planning to be, you may wonder whether it is a safe choice. Here the picture is generally reassuring: methyldopa is one of the oldest and most studied blood-pressure medicines used during pregnancy, and it has a long track record in this setting. This article gathers what leading sources say so you can have a more informed conversation with the clinician who manages your pregnancy. It is general education only and is not a substitute for that conversation.

What methyldopa is and what it treats

Methyldopa is a medicine used to treat high blood pressure. According to MedlinePlus, it works by relaxing the blood vessels so that blood can flow more easily through the body, which brings blood pressure down. It acts centrally, in the brain’s blood-pressure control pathways, rather than directly on the heart. In pregnancy it is used both for ongoing (chronic) high blood pressure and for high blood pressure that develops during pregnancy.

What the guidance says about methyldopa in pregnancy

Methyldopa is notable for its long history of use in pregnancy. Because it has been used for decades and followed in long-term studies of exposed children, it is often described as having one of the most established safety records among blood-pressure medicines in pregnancy. It has traditionally been a first-line choice, and professional guidance, including from the American College of Obstetricians and Gynecologists (ACOG) as summarized in the medical literature, continues to recognize it as an acceptable option for treating high blood pressure in pregnancy.

That said, guidance has evolved, and the “first-line” label varies by source. Some newer guidelines now list other agents, such as labetalol or nifedipine, as preferred initial choices, in part because methyldopa may not lower blood pressure as strongly and can cause drowsiness. Under the UK’s NICE guidance, for example, labetalol is offered first, with nifedipine and then methyldopa as alternatives. The practical point is that methyldopa remains a well-established, acceptable option, and which medicine is best for you is an individual decision for your care team.

Birth defects and miscarriage

The UK Teratology Information Service (UKTIS) reports that the available data do not demonstrate an increased overall risk of congenital malformation or of miscarriage following first-trimester use of methyldopa. It notes that a small number of individual studies have raised possible associations with specific defects, but that further analysis is needed to confirm or refute these, and they are not considered established. Overall, the long experience with this medicine is a large part of why it is trusted in pregnancy.

Effects on the baby and pregnancy

UKTIS indicates that the available data do not show increased concern regarding preterm delivery, being small for gestational age, perinatal death, newborn complications, or later neurodevelopment specifically related to methyldopa exposure. It also notes that exposure to methyldopa is not by itself a reason for additional fetal monitoring. As with any medicine, your care team decides on monitoring based on your overall situation, not the medication alone.

The other side: untreated high blood pressure is dangerous

It is important not to read any caution as a reason to stop treatment. Poorly controlled high blood pressure in pregnancy is associated with serious risks to both parent and baby, including complications such as pre-eclampsia, problems with the baby’s growth, and preterm birth. This is a major reason clinicians treat elevated blood pressure in pregnancy rather than leaving it alone, and why medicines with a good track record in pregnancy, such as methyldopa, are used. The goal of care is safe, effective blood-pressure control, not avoiding all medicine.

Do not stop methyldopa on your own

This point deserves emphasis. MedlinePlus specifically warns not to stop taking methyldopa without talking to your doctor, because suddenly stopping it can cause blood pressure to rise and can bring on side effects. On top of that, uncontrolled high blood pressure is itself risky in pregnancy. If you are worried about your medicine, the safe move is to talk with the prescriber who manages it rather than pausing it yourself. Any change in dose or medication should be made with your clinician, who can adjust things safely.

Side effects and after delivery

MedlinePlus notes that methyldopa can cause drowsiness, especially when you first start it or after a dose increase, so caution with driving may be advised at those times. Some guidance also suggests moving away from methyldopa in the days after delivery, out of caution about a possible link to depression in the postpartum period, and switching to a different blood-pressure medicine if ongoing treatment is needed. This is a decision for your care team based on your history; do not make the switch on your own.

A note on drug “categories”

You may see older references sorting pregnancy medicines into letter categories such as A, B, C, D, and X. Those FDA letter categories have been retired. They were replaced with a narrative labeling system (the Pregnancy and Lactation Labeling Rule) that describes what is actually known from studies rather than assigning a single letter. If you come across an old “category” for methyldopa, treat it as outdated and rely on current guidance and your care team.

When to call your OB or a specialist

Contact your obstetric provider promptly if you have very high blood pressure readings, a severe headache, changes in vision, swelling that comes on suddenly, upper-abdominal pain, or reduced fetal movement later in pregnancy, as these can be signs of a hypertensive complication that needs urgent care. If your blood pressure is difficult to control, your provider may involve a maternal-fetal-medicine specialist. For questions about a specific medication exposure in pregnancy or breastfeeding, you can also call MotherToBaby at 1-866-626-6847, a free service that answers questions about medicines and other exposures.

Frequently asked questions

Is methyldopa safe to take while pregnant? Methyldopa is one of the most established blood-pressure medicines in pregnancy, and available data do not show a clear increase in the overall chance of birth defects or miscarriage. Whether it is right for you is a decision for your care team.

Is methyldopa still a first-line medicine in pregnancy? It has traditionally been a first-line choice and remains an acceptable option. Some newer guidelines now list agents such as labetalol or nifedipine first, so the label varies by source.

Can I just stop methyldopa if I’m worried? No. MedlinePlus warns not to stop it without talking to your doctor, because blood pressure can rise and side effects can appear. Uncontrolled high blood pressure is itself risky in pregnancy.

Why does methyldopa make me sleepy? Drowsiness is a known side effect, often strongest when starting or increasing the dose. Tell your provider if it is bothersome; do not adjust the dose yourself.

Will I keep taking methyldopa after delivery? Some guidance suggests switching to a different blood-pressure medicine after delivery because of a possible link to postpartum depression. Your care team will decide based on your history.

What if my blood pressure is still high on methyldopa? Contact your provider. They may adjust the dose or add or change medicines. Do not adjust the dose yourself.

Sources

• MedlinePlus (U.S. National Library of Medicine) — Methyldopa drug information.
• UK Teratology Information Service (UKTIS) — Use of Methyldopa in Pregnancy monograph.
• American College of Obstetricians and Gynecologists (ACOG) — guidance recognizing methyldopa among acceptable antihypertensives in pregnancy, as summarized in peer-reviewed literature.